Doç. Dr. Doğan Yazılıtaş
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Breast Neoplasms 8 publicationsSource: OpenAlex / PubMed MeSHView publications
- Lung Neoplasms 5 publications
- Head and Neck Neoplasms 4 publications
- Squamous Cell Carcinoma of Head and Neck 2 publications
- Neoplasms 2 publications
- Colonic Neoplasms 2 publications
- Rectal Neoplasms 2 publications
- Liver Neoplasms 2 publications
- Sarcoma 2 publications
- Stomach Neoplasms 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- Department name at the sourceOnkolojisaglik.gov.trFrom source
- InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
- Area of workBreast NeoplasmsExtracted from 8 publications · Model version —From source
- Publications101 publicationsOpenAlex, Europe PMC, ORCIDFrom source
- ORCID0000-0003-3850-7870ORCIDFrom source
- Last synchronised5 November 2026 07:23https://etliksehir.saglik.gov.tr/TR-864408/klinik-doktorlarimiz.html#dogan-yazilitassaglik.gov.tr
Scientific work
Publications on Breast Neoplasms
-
Quantifying the Survival Benefit of Trimodality Therapy in Esophageal Squamous Cell Carcinoma: An IPTW-adjusted Retrospective Analysis
Acta haematologica oncologica Turcica., 2026
DOI 10.4274/ahot.galenos.2026.2026-4-6 Open-access full textSource: OpenAlex
-
Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors
Expert review of anticancer therapy, 2026
DOI 10.1080/14737140.2026.2733826 PMID 42733172 Source: Europe PMC
-
Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors
Figshare, 2026
DOI 10.6084/m9.figshare.33717648 Open-access full textSource: OpenAlex
-
Prognostic Role of Nutritional and Inflammatory Indices in Predicting Adverse Clinical Outcomes in Unplanned Hospitalized Oncology Patients
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15082992 PMID 42074794 2 citations (OpenAlex) Open-access full textSource: OpenAlex
-
Prognostic value of pan-immune-inflammation index in hepatocellular carcinoma compared with albumin-bilirubin and model for end-stage liver disease sodium
World Journal of Gastrointestinal Oncology, 2026
DOI 10.4251/wjgo.121250 Open-access full textSource: OpenAlex
-
Fear of Cancer Recurrence and Psychological Symptom Burden in Breast Cancer Survivors Without Evidence of Active Disease: A Cross-Sectional Real-World Study
Healthcare (Basel, Switzerland), 2026
DOI 10.3390/healthcare14162665 PMID 42651434 Open-access full textSource: Europe PMC
-
Evaluation of definitively treated early and locally advanced malignant salivary gland tumors
Asian Journal of Surgery, 2026
DOI 10.1016/j.asjsur.2025.09.131 Open-access full textSource: ORCID
-
159eP Prognostic value of the immune checkpoint inhibitor score (IChIS) in palliative immunotherapy-treated non-small cell lung cancer: A real-world study
ESMO Open, 2026
DOI 10.1016/j.esmoop.2026.106466 Open-access full textSource: OpenAlex
-
Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy
Discover Oncology, 2026
DOI 10.1007/s12672-026-04938-w PMID 41979751 Open-access full textSource: OpenAlex
-
Real-World Evaluation of the Immune Checkpoint Inhibitor Score (IChIS) in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15197750 PMID 42882209 Open-access full textSource: OpenAlex